#40 'Drug Dealer M.D.' Author, Dr. Anna Lembke, discusses the latest addiction treatments
Release Date: 07/17/2020
#63 Dr. Deborah Korn on EMDR: A Proven Treatment for PTSD and Complex PTSD
Therapy Show
is a clinical psychologist in private practice in Cambridge, Massachusetts, and an adjunct training faculty member at the Trauma Research Foundation in Boston. Dr. Korn is a senior faculty member at the EMDR Institute where she has been on staff for the past 28 years. She is an EMDRIA Approved Consultant and serves on the editorial board of the Journal of EMDR Practice and Research. EMDRIA is the organization focused on promoting, fostering, and preserving the highest standards of excellence and integrity in EMDR research, treatment, and education both in United States and internationally....
info_outline
#62 Dr. Nicole Stadnick, Autism Expert, on Why an Integrated Approach to Treatment is Critical
Therapy Show
Dr. Nicole Stadnick is a Psychologist, Assistant Professor in the Department of Psychiatry at the University of California San Diego, Director of Dissemination and Evaluation of the Altman Clinical and Translational Research Institute Dissemination and Implementation Science Center and investigator in the Child and Adolescent Services Research Center. A primary area of Dr. Stadnick’s research aims to promote equitable access to evidence-based practices and mental health services for children with Autism Spectrum Disorder and co-occurring mental health needs through tailored service delivery...
info_outline
#61 Dr. Elizabeth Nielson on Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder: Possible Anti-Addictive Properties
Therapy Show
is a co-founder of and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a Site Co-Principal Investigator and therapist for an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and has served as a therapist on FDA approved clinical trials of Psilocybin-Assisted treatment of Alcohol Use Disorder, psilocybin-assisted treatment of treatment resistant depression, and earlier phase 2 and 3 trials of MDMA-assisted...
info_outline
#60 Dr. William Miller on Motivational Interviewing: A Powerful Therapy for Mental Health and Physical Health
Therapy Show
is Emeritus Distinguished Professor of Psychology and Psychiatry at the University of New Mexico, with over forty years of experience in teaching. Dr. Miller is a researcher and developer of the therapeutic model . His many books include and . Dr. Miller's latest book, , was released in January 2019. is a collaborative conversation that strengthens a person's own motivation for and commitment to change. It is a client-centered therapy that addresses the common problem of uncertainty around change. It focuses on exploring and working through ambivalence and centers on motivational processes...
info_outline
#59 Dr. Stefan Hofmann on Simple CBT and Mindfulness Strategies to Overcome Anxiety, Fear, and Worry
Therapy Show
is a professor in the clinical program at Boston University and the Director of the Psychotherapy and Emotion Research Laboratory at the Center for Anxiety and Related Disorders. Some of Dr. Hofmann’s research questions include: Why are psychological treatments, such as cognitive-behavioral therapy, effective for anxiety disorders? What is the mechanism of treatment change, and what are the active ingredients? How can these treatments be improved further? Dr. Hofmann is the Editor in Chief of Cognitive Therapy and Research and is Associate Editor of Clinical...
info_outline
#58 Dr. Ingmar Gorman on MDMA-Assisted Psychotherapy for PTSD: A Potential Front-line Treatment
Therapy Show
is a co-founder of , a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike. Dr. Gorman received his clinical training in New York City at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University. He simultaneously served as site co-principal investigator on an FDA approved Phase 3 clinical trial of...
info_outline
#57 Dr. Steven Hayes Developed ACT to Help Individuals Balance Acceptance and Change Leading to Emotional Flexibility
Therapy Show
is Nevada Foundation Professor at the Department of Psychology at the University of Nevada and the developer of a new approach to human thought called Relational Frame Theory. He has guided ACT’s extension to Acceptance and Commitment Therapy (ACT) a popular evidence-based form of psychotherapy that is now practiced by tens of thousands of clinicians all around the world. Dr. Hayes was listed by the Institute of Scientific Information as the 30th “highest impact” psychologist in the world. Dr. Hayes is the author of many seminal books includin and my favorite . Whether...
info_outline
#56 Dr. Elaine Walker, Renowned Schizophrenia Expert, on Why Early Intervention is Critical to Effective Treatment
Therapy Show
is the Charles Howard Candler Professor of Psychology and Neuroscience at Emory College’s Department of Psychology and her research focuses on the precursors and neurodevelopmental aspects of psychopathology of schizophrenia. Schizophrenia and other psychotic disorders are major mental illnesses that involve an abnormality in central nervous system functioning. Dr. Walker’s research program is concerned with shedding light on the nature and origins of this abnormality, its interaction with neuromaturational processes and the role of environmental stressors in triggering psychotic...
info_outline
#55 Dr. Frederic Reamer on Boundary Issues and Dual Relationships in Social Work Practice
Therapy Show
is a Professor in the School of Social Work at Rhode Island College for over 30 years. He received his PhD from the University of Chicago and has served as a social worker in correctional and mental health settings. Dr. Reamer chaired the national task force that wrote the adopted in 1996 and recently participated in drafting new added to the code in 2017. Dr. Reamer lectures both nationally and internationally on the subjects of professional ethics and professional malpractice and liability. He has conducted extensive research on professional ethics and has been involved in...
info_outline
#54 DBT in Schools: Teach Kids Social Emotional Skills BEFORE They Develop a Mental Disorder
Therapy Show
is licensed psychologist, a certified DBT therapist and co-author of the DBT STEPS-A social emotional learning curriculum for middle and high school students. Dr. Dexter-Mazza completed her postdoctoral fellowship under the direction of Dr. Marsha Linehan at the Behavioral Research and Therapy Clinics (BRTC) at the University of Washington. While at the BRTC, she was the Clinical Director and a research therapist for Dr. Linehan’s research studies, which provided both individual DBT and DBT group skills training. Dr. Dexter-Mazza is the co-author of . She has published several book...
info_outlineDr. Anna Lembke is an associate professor in the department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is Medical Director of Stanford Addiction Medicine, Program Director for the Stanford Addiction Medicine Fellowship, and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke was one of the first in the medical community to sound the alarm regarding opioid overprescribing and the opioid epidemic. In 2016, she published her best-selling book on the prescription drug epidemic, Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop. Her book was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic.
Substance Use Disorder is a syndrome where a person compulsively uses substances despite many negative experiences and harmful consequences. Individuals who experience severe substance use disorder symptoms have an intense desire to use certain substances like alcohol or drugs, regardless of the problems that come about by consuming them. Gambling Disorder is new to the DSM-5 and is characterized by repeated gambling despite extremely negative consequences affecting the whole family.
Disclaimer: The information shared in this podcast is not a substitute for getting help from a mental health professional.